FORWARD-LOOKING STATEMENTS AND ASSOCIATED RISKS All statements included or incorporated by reference in this Form 10-K and other filings with the U.S. Securities and Exchange Commission (the “SEC”) that do not directly and exclusively relate to historical facts constitute “forward-looking statements.” These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. No assurance can be given that any expectation, belief, goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 3.7B | 3.7B | 3.8B | 4.0B | 3.9B | 4.2B |
| Net Income | -598M | -598M | -910M | -132M | -950M | 411M |
| EPS | $-3.00 | $-3.00 | $-4.48 | $-0.62 | $-4.41 | $1.87 |
| Free Cash Flow | 104M | 104M | 281M | 228M | 368M | 515M |
| ROIC | -8.7% | -17.4% | -21.1% | -2.5% | -15.1% | 6.7% |
| Gross Margin | 50.0% | 50.0% | 51.6% | 52.6% | 54.2% | 55.5% |
| Debt/Equity | 2.10 | 2.10 | 1.04 | 0.66 | 0.52 | 0.46 |
| Dividends/Share | $0.64 | $0.64 | $0.64 | $0.56 | $0.50 | $0.43 |
| Operating Income | -422M | -422M | -879M | -85M | -937M | 608M |
| Operating Margin | -11.5% | -11.5% | -23.2% | -2.1% | -23.9% | 14.4% |
| ROE | -44.7% | -36.5% | -34.8% | -3.7% | -21.6% | 8.3% |
| Shares Outstanding | 199M | 199M | 203M | 213M | 215M | 220M |
DENTSPLY SIRONA Inc. passes 3 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 23.5x vs a median of 22.0x. The company's 5-year average gross margin is 52.8%. Total shareholder yield (dividends) is 5.3%. At current prices, the estimated annualized return to fair value is -12.9%.
DENTSPLY SIRONA Inc. (XRAY) has a 5-year average return on invested capital (ROIC) of -9.9%. This is below average and may indicate limited pricing power.
DENTSPLY SIRONA Inc. (XRAY) has a market capitalization of $2.4B. It is classified as a mid-cap stock.
Yes, DENTSPLY SIRONA Inc. (XRAY) pays a dividend with a trailing twelve-month yield of 5.25%.
DENTSPLY SIRONA Inc. (XRAY) operates in the Dental Equipment & Supplies industry, within the Healthcare sector.
DENTSPLY SIRONA Inc. (XRAY) reported annual revenue of $3.7 billion in its most recent fiscal year, based on SEC EDGAR filings.
DENTSPLY SIRONA Inc. (XRAY) has a net profit margin of -16.3%. The company is currently unprofitable.
DENTSPLY SIRONA Inc. (XRAY) generated $104 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
DENTSPLY SIRONA Inc. (XRAY) has a debt-to-equity ratio of 2.10. This indicates higher leverage, which may increase financial risk.
DENTSPLY SIRONA Inc. (XRAY) reported earnings per share (EPS) of $-3.00 in its most recent fiscal year.
DENTSPLY SIRONA Inc. (XRAY) has a return on equity (ROE) of -36.5%. A negative ROE may indicate losses or negative equity.
DENTSPLY SIRONA Inc. (XRAY) has a 5-year average gross margin of 52.8%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 16 years of financial data for DENTSPLY SIRONA Inc. (XRAY), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
DENTSPLY SIRONA Inc. (XRAY) has a book value per share of $6.72, based on its most recent annual SEC filing.